Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. / Eskesen, K; Jensen, M T; Galatius, S; Vestergaard, H; Hildebrandt, P; Marott, J L; Jensen, J S.

In: Journal of Internal Medicine, Vol. 273, No. 1, 2013, p. 94-101.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Eskesen, K, Jensen, MT, Galatius, S, Vestergaard, H, Hildebrandt, P, Marott, JL & Jensen, JS 2013, 'Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study', Journal of Internal Medicine, vol. 273, no. 1, pp. 94-101. https://doi.org/10.1111/j.1365-2796.2012.02594.x

APA

Eskesen, K., Jensen, M. T., Galatius, S., Vestergaard, H., Hildebrandt, P., Marott, J. L., & Jensen, J. S. (2013). Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. Journal of Internal Medicine, 273(1), 94-101. https://doi.org/10.1111/j.1365-2796.2012.02594.x

Vancouver

Eskesen K, Jensen MT, Galatius S, Vestergaard H, Hildebrandt P, Marott JL et al. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. Journal of Internal Medicine. 2013;273(1):94-101. https://doi.org/10.1111/j.1365-2796.2012.02594.x

Author

Eskesen, K ; Jensen, M T ; Galatius, S ; Vestergaard, H ; Hildebrandt, P ; Marott, J L ; Jensen, J S. / Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. In: Journal of Internal Medicine. 2013 ; Vol. 273, No. 1. pp. 94-101.

Bibtex

@article{18a0b7bc67544f22b7938d0a9079a098,
title = "Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study",
abstract = "Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.",
author = "K Eskesen and Jensen, {M T} and S Galatius and H Vestergaard and P Hildebrandt and Marott, {J L} and Jensen, {J S}",
note = "{\circledC} 2012 The Association for the Publication of the Journal of Internal Medicine.",
year = "2013",
doi = "10.1111/j.1365-2796.2012.02594.x",
language = "English",
volume = "273",
pages = "94--101",
journal = "Acta Medica Scandinavica",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study

AU - Eskesen, K

AU - Jensen, M T

AU - Galatius, S

AU - Vestergaard, H

AU - Hildebrandt, P

AU - Marott, J L

AU - Jensen, J S

N1 - © 2012 The Association for the Publication of the Journal of Internal Medicine.

PY - 2013

Y1 - 2013

N2 - Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.

AB - Individuals with diabetes mellitus (DM) have a considerably elevated risk of developing serious health problems including cardiovascular disease (CVD). Long-term elevated levels of blood glucose in nondiabetic individuals may also be associated with increased risk of CVD. The aim of this study was to investigate the relationships between glycated haemoglobin A(1c) (HbA(1c) ) and CVD, DM and all-cause mortality.

U2 - 10.1111/j.1365-2796.2012.02594.x

DO - 10.1111/j.1365-2796.2012.02594.x

M3 - Journal article

VL - 273

SP - 94

EP - 101

JO - Acta Medica Scandinavica

JF - Acta Medica Scandinavica

SN - 0955-7873

IS - 1

ER -

ID: 48476960